ENASIDENIB for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 181 adverse event reports in the FDA FAERS database where ENASIDENIB was used for Off label use.
Most Reported Side Effects for ENASIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 650 | 17.6% | 650 | 14 |
| Off label use | 213 | 5.8% | 26 | 35 |
| Fatigue | 202 | 5.5% | 5 | 41 |
| Nausea | 197 | 5.3% | 5 | 40 |
| Acute myeloid leukaemia | 163 | 4.4% | 95 | 43 |
| Hospitalisation | 149 | 4.0% | 2 | 145 |
| Diarrhoea | 144 | 3.9% | 1 | 35 |
| Decreased appetite | 122 | 3.3% | 3 | 35 |
| Platelet count decreased | 113 | 3.1% | 3 | 45 |
| Drug ineffective | 108 | 2.9% | 7 | 16 |
| Differentiation syndrome | 102 | 2.8% | 19 | 66 |
| Pneumonia | 91 | 2.5% | 14 | 69 |
| Pyrexia | 90 | 2.4% | 9 | 71 |
| Asthenia | 89 | 2.4% | 2 | 39 |
| Full blood count decreased | 75 | 2.0% | 2 | 37 |
Other Indications for ENASIDENIB
Acute myeloid leukaemia (2,220)
Product used for unknown indication (657)
Myelodysplastic syndrome (304)
Myeloid leukaemia (58)
Leukaemia (55)
Acute myeloid leukaemia recurrent (51)
Cholangiocarcinoma (48)
Glioma (34)
Acute myelomonocytic leukaemia (32)
Acute myeloid leukaemia (in remission) (31)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)